HSØ: Cellular neovascularisation in the treatment of peripheral vascular disease, 2,8 MNOK, 05/2014 11/2017 (Including maternity leave)
HSØ: MicroRNA-140 in pathogenesis and treatment of osteoarthritis. 2,8 MNOK, 03/2015 03/2018
HSØ: MicroRNAs as biomarkers and therapeutic agents for osteoarthritis. 2,8 MNOK. 10/2016 10/2019 (Post doc not yet in the group)
Stem Cell Center/ORMeC: Tissue engineering of articular cartilage. 1,4 MNOK. 09/2016 09/2018 (Post doc not yet in the group.